Sponsor Pipeline

Quell Therapeutics Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07473154 Controlling Hyperactive Immunity With Long-lived Lymphocytes Diffuse Cutaneous Systemic Sclerosis Recruiting
NCT05234190 Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients Rejection; Transplant, Liver Active, Not Recruiting
Not specified
NCT04838171 Prospective Study of White Blood Cells Autoimmune Diseases Recruiting
Disease Areas
Rheumatoid Arthritis (1) Scleroderma (1)
Get alerts when Quell Therapeutics Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free